Form 4: Core Scientific Director Yadin Rozov Acquires Shares Through Restricted Stock Unit Grant

Director Yadin Rozov of Core Scientific, Inc. acquired 20,448 shares through a restricted stock unit grant.

Summary

• Yadin Rozov, a director at Core Scientific, Inc., acquired 20,448 shares of common stock.
• The acquisition was in the form of a restricted stock unit (RSU) grant.
• The RSUs will vest fully on January 27, 2026, provided Mr. Rozov continues to serve as a non-employee director until that date.
• The transaction occurred on January 27, 2025.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of a director receiving a standard RSU grant, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The RSU grant aligns the director's interests with the long-term performance of the company.
• The vesting period encourages continued service and commitment from the director.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service until January 27, 2026.

Industry Context

This is a standard practice for compensating board members and aligning their interests with shareholders in publicly traded companies.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across various industries, including technology and finance.
• The vesting period of one year is also a typical timeframe for such grants, aligning with standard corporate governance practices.
• Companies like Marathon Digital Holdings and Riot Platforms also use similar equity-based compensation for their board members.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, encouraging long-term value creation.

Key Dates

Keywords

Core Scientific, Director, Yadin Rozov, Restricted Stock Units, RSU, Share Acquisition, Beneficial Ownership, SEC Form 4